These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


217 related items for PubMed ID: 23703612

  • 1. Interaction between Her2 and Beclin-1 proteins underlies a new mechanism of reciprocal regulation.
    Han J, Hou W, Lu C, Goldstein LA, Stolz DB, Watkins SC, Rabinowich H.
    J Biol Chem; 2013 Jul 12; 288(28):20315-25. PubMed ID: 23703612
    [Abstract] [Full Text] [Related]

  • 2. Roles of BIM induction and survivin downregulation in lapatinib-induced apoptosis in breast cancer cells with HER2 amplification.
    Tanizaki J, Okamoto I, Fumita S, Okamoto W, Nishio K, Nakagawa K.
    Oncogene; 2011 Sep 29; 30(39):4097-106. PubMed ID: 21499301
    [Abstract] [Full Text] [Related]

  • 3. Lapatinib induces autophagic cell death and inhibits growth of human hepatocellular carcinoma.
    Chen YJ, Chi CW, Su WC, Huang HL.
    Oncotarget; 2014 Jul 15; 5(13):4845-54. PubMed ID: 24947784
    [Abstract] [Full Text] [Related]

  • 4. PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim.
    Park SH, Ito K, Olcott W, Katsyv I, Halstead-Nussloch G, Irie HY.
    Breast Cancer Res; 2015 Jun 19; 17(1):86. PubMed ID: 26084280
    [Abstract] [Full Text] [Related]

  • 5. Increased autophagy blocks HER2-mediated breast tumorigenesis.
    Vega-Rubín-de-Celis S, Zou Z, Fernández ÁF, Ci B, Kim M, Xiao G, Xie Y, Levine B.
    Proc Natl Acad Sci U S A; 2018 Apr 17; 115(16):4176-4181. PubMed ID: 29610308
    [Abstract] [Full Text] [Related]

  • 6. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
    Salminen A, Kaarniranta K, Kauppinen A, Ojala J, Haapasalo A, Soininen H, Hiltunen M.
    Prog Neurobiol; 2013 Apr 17; 106-107():33-54. PubMed ID: 23827971
    [Abstract] [Full Text] [Related]

  • 7. RFX1-dependent activation of SHP-1 induces autophagy by a novel obatoclax derivative in hepatocellular carcinoma cells.
    Su JC, Tseng PH, Hsu CY, Tai WT, Huang JW, Ko CH, Lin MW, Liu CY, Chen KF, Shiau CW.
    Oncotarget; 2014 Jul 15; 5(13):4909-19. PubMed ID: 24952874
    [Abstract] [Full Text] [Related]

  • 8. Puquitinib mesylate (XC-302) induces autophagy via inhibiting the PI3K/AKT/mTOR signaling pathway in nasopharyngeal cancer cells.
    Wang KF, Yang H, Jiang WQ, Li S, Cai YC.
    Int J Mol Med; 2015 Dec 15; 36(6):1556-62. PubMed ID: 26499488
    [Abstract] [Full Text] [Related]

  • 9. Induction of autophagy is an early response to gefitinib and a potential therapeutic target in breast cancer.
    Dragowska WH, Weppler SA, Wang JC, Wong LY, Kapanen AI, Rawji JS, Warburton C, Qadir MA, Donohue E, Roberge M, Gorski SM, Gelmon KA, Bally MB.
    PLoS One; 2013 Dec 15; 8(10):e76503. PubMed ID: 24146879
    [Abstract] [Full Text] [Related]

  • 10. Autophagy induced by suberoylanilide hydroxamic acid in Hela S3 cells involves inhibition of protein kinase B and up-regulation of Beclin 1.
    Cao Q, Yu C, Xue R, Hsueh W, Pan P, Chen Z, Wang S, McNutt M, Gu J.
    Int J Biochem Cell Biol; 2008 Dec 15; 40(2):272-83. PubMed ID: 17881280
    [Abstract] [Full Text] [Related]

  • 11. An heregulin-EGFR-HER3 autocrine signaling axis can mediate acquired lapatinib resistance in HER2+ breast cancer models.
    Xia W, Petricoin EF, Zhao S, Liu L, Osada T, Cheng Q, Wulfkuhle JD, Gwin WR, Yang X, Gallagher RI, Bacus S, Lyerly HK, Spector NL.
    Breast Cancer Res; 2013 Dec 15; 15(5):R85. PubMed ID: 24044505
    [Abstract] [Full Text] [Related]

  • 12. Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of Akt-mediated gene repression.
    Nencioni A, Cea M, Garuti A, Passalacqua M, Raffaghello L, Soncini D, Moran E, Zoppoli G, Pistoia V, Patrone F, Ballestrero A.
    PLoS One; 2010 Feb 02; 5(2):e9024. PubMed ID: 20126311
    [Abstract] [Full Text] [Related]

  • 13. OSU-03012 interacts with lapatinib to kill brain cancer cells.
    Booth L, Cruickshanks N, Ridder T, Chen CS, Grant S, Dent P.
    Cancer Biol Ther; 2012 Dec 02; 13(14):1501-11. PubMed ID: 22990204
    [Abstract] [Full Text] [Related]

  • 14. Protective autophagy promotes the resistance of HER2-positive breast cancer cells to lapatinib.
    Chen S, Zhu X, Qiao H, Ye M, Lai X, Yu S, Ding L, Wen A, Zhang J.
    Tumour Biol; 2016 Feb 02; 37(2):2321-31. PubMed ID: 26369543
    [Abstract] [Full Text] [Related]

  • 15. The Bcl-2 homology domain 3 mimetic gossypol induces both Beclin 1-dependent and Beclin 1-independent cytoprotective autophagy in cancer cells.
    Gao P, Bauvy C, Souquère S, Tonelli G, Liu L, Zhu Y, Qiao Z, Bakula D, Proikas-Cezanne T, Pierron G, Codogno P, Chen Q, Mehrpour M.
    J Biol Chem; 2010 Aug 13; 285(33):25570-81. PubMed ID: 20529838
    [Abstract] [Full Text] [Related]

  • 16. Erlotinib-induced autophagy in epidermal growth factor receptor mutated non-small cell lung cancer.
    Li YY, Lam SK, Mak JC, Zheng CY, Ho JC.
    Lung Cancer; 2013 Sep 13; 81(3):354-361. PubMed ID: 23769318
    [Abstract] [Full Text] [Related]

  • 17. MET activation mediates resistance to lapatinib inhibition of HER2-amplified gastric cancer cells.
    Chen CT, Kim H, Liska D, Gao S, Christensen JG, Weiser MR.
    Mol Cancer Ther; 2012 Mar 13; 11(3):660-9. PubMed ID: 22238368
    [Abstract] [Full Text] [Related]

  • 18. Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells.
    Jin Q, Yuan LX, Boulbes D, Baek JM, Wang YN, Gomez-Cabello D, Hawke DH, Yeung SC, Lee MH, Hortobagyi GN, Hung MC, Esteva FJ.
    Breast Cancer Res; 2010 Mar 13; 12(6):R96. PubMed ID: 21080941
    [Abstract] [Full Text] [Related]

  • 19. PUMA and BIM are required for oncogene inactivation-induced apoptosis.
    Bean GR, Ganesan YT, Dong Y, Takeda S, Liu H, Chan PM, Huang Y, Chodosh LA, Zambetti GP, Hsieh JJ, Cheng EH.
    Sci Signal; 2013 Mar 26; 6(268):ra20. PubMed ID: 23532334
    [Abstract] [Full Text] [Related]

  • 20. Autophagy stimulates apoptosis in HER2-overexpressing breast cancers treated by lapatinib.
    Zhu X, Wu L, Qiao H, Han T, Chen S, Liu X, Jiang R, Wei Y, Feng D, Zhang Y, Ma Y, Zhang S, Zhang J.
    J Cell Biochem; 2013 Dec 26; 114(12):2643-53. PubMed ID: 23794518
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.